<DOC>
	<DOCNO>NCT01232790</DOCNO>
	<brief_summary>The purpose study evaluate effect amino acid supplement N-Acetylcysteine versus placebo work memory cognitive function person diagnosis schizophrenia .</brief_summary>
	<brief_title>A Pilot Trial Acute N-Acetylcysteine Effects Working Memory Other Cognitive Functions Schizophrenia</brief_title>
	<detailed_description>Working memory impairment Schizophrenia produce deficiency feedback inhibition glutamate release , due low cysteine-glutamate antiporter activity . Because mechanism , interested whether acute administration N-Acetylcysteine improve performance patient schizophrenia battery cognitive task utilized test work memory cognitive domain , versus placebo . This pilot study utilize randomize , double blind , placebo control , crossover design .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Subjects 1860 Meet Diagnostic Statistical ManualIV ( DSM ) criterion schizophrenia Be stable dose antipsychotic medication least 1 month Be deem clinically stable 3 month regular clinical staff Current substance alcohol abuse Pregnancy Clozapine treatment Known sensitivity sulphur contain compound Previous diagnosis mental retardation Nitroglycerin use Asthma diagnosis , verify treat primary care doctor Use medication may interact study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>work memory</keyword>
	<keyword>N-Acetylcysteine</keyword>
</DOC>